Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 8/17/23 → 8/17/25 |
Funding
- Cavion Incorporated: $61,406.00
JZP385-202: A 17-week, Phase 2, Randomized, Double-blind, Placebo-controlled, Flexible-dosing, Parallel-group, Multicenter Study of the Efficacy and Safety of Suvecaltamide in the Treatment of Moderate to Severe Residual Tremor in Participants with Parkin
- Guduru, Zain (PI)